Healthcare >> CEO Interviews >> June 12, 2000
MANFRED K. KRUEGER is President and Chief Executive Officer of Tutogen
Medical, Inc. Under his guidance, Tutogen's revenues have increased 29%
over the last year, and its net income was more than three times that of
1998. He continues to transform Tutogen from a tissue processing company
to a significant medical device manufacturer. Under his leadership,
Tutogen has recently entered into a strategic alliance with Sulzer
Medica for the worldwide distribution of its patented state-of-the-art
Tutoplast' processed bone tissue for spinal applications. Prior to
joining the company in June 1997, Mr. Krueger was Executive Vice
President of Fresenius Critical Care International, a division of
Fresenius Medical Care, AG. The division was founded in 1991 under his
leadership and grew into a substantial business with an average annual
growth of approximately 40%. Prior to Fresenius, Mr. Krueger held
management positions with Squibb Medical Systems and American Hospital
Supply. Profile
Mr. Krueger: Tutogen was re-established about six years ago and was a
spin off of a pharmaceutical company in Germany. The
